’The interplay between DNA damage and histone mutations in pediatric gliomas’ |
Dana-Farber Cancer Institute |
Northwestern Mutual Foundation |
Exploring the Immune Effects of Photodynamic Therapy Treatment on Diffuse Midline Glioma Progression |
Icahn School of Medicine at Mount Sinai |
Northwestern Mutual Foundation |
Wilms tumor risk and management in WAGR Syndrome |
Children’s Hospital of Philadelphia |
Northwestern Mutual Foundation |
L15/TGF-beta trap fusokine for treatment of pediatric sarcomas |
The Board of Regents of the University of Wisconsin System |
Northwestern Mutual Foundation |
DEFINING GENETIC DRIVER MUTATIONS,CLINIC CHARACTERISTICS & OUTCOMES IN CHILDREN & YOUNG ADULTS WITH HISTIOCYTOSES |
Baylor College of Medicine |
Northwestern Mutual Foundation |
Families of Children with Advanced Cancer: The Impact of Social Determinants of Health |
Research Institute at Nationwide Children's Hospital |
Northwestern Mutual Foundation |
Delivering on the Promise of Germline Genetic Testing for RUNX1 Variants |
University of Washington, Seattle |
The RUNX1 Research Program |
Using Chemical Genetics to Define the Precise Role of RUNX1 in Transcription and Beyond |
Albert Einstein College of Medicine |
The RUNX1 Research Program |
Understanding and inhibiting mechanisms of metastatic spread in osteosarcoma |
University of California San Francisco |
The Bryce Bazor Foundation |
Social Determinants of Health, Hospital-level Resources, and Risk of Septic Shock in Pediatric Leukemia |
Children’s Hospital of Philadelphia |
Northwestern Mutual Foundation |